
Gameto, a biotech firm, pioneers in female reproductive health therapies, using cellular engineering for effective treatments.
Gameto, founded with a mission to redefine female reproductive health, is a biotechnology company focused on developing advanced therapies to address the underserved area of women's health. Utilizing cutting-edge cellular engineering, Gameto offers innovative solutions for conditions ranging from egg freezing and infertility to menopause and other reproductive diseases. Their products aim to provide more effective treatments with fewer complications, significantly improving the quality of life for women.
Notable figures affiliated with Gameto include leading scientists and healthcare professionals dedicated to advancing women's health. The company has garnered attention from prominent investors in the biotech sector, reflecting confidence in its groundbreaking approach. Key achievements include landmark research published in reputable journals like Human Reproduction and eLife, highlighting their scientific contributions. Gameto's impact lies in its commitment to delivering better clinical outcomes and setting new standards in female reproductive health.

Granata Bio
granata.bio

JumpStart Fertility

Conceivable Life Sciences
conceivable.life

Microgenesis
microgenesis.net

ReproHealth Technologies

Cofertility
cofertility.com

Ivy Natal
ivynatal.com

Carrot Fertility
get-carrot.com

She's Well
sheswell.co

MedAnswers

GentiBio
gentibio.com

Darwin Life

Incept BioSystems

JangoBio
jango.bio

Cell BioEngines
cellbioengines.com
Companies similar to Gameto include Granata Bio, JumpStart Fertility, Conceivable Life Sciences and Microgenesis.
Gameto was founded in 2020.
Gameto's headquarters is located in New York City, NY, US.
Gameto's most recent funding round was for $17M (USD) in September 2022.
As of Sep 14, 2022, Gameto has raised a total of $40M (USD).
Gameto has 37 employees as of Feb 5, 2024.